List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 167 studies with search of: Hepatitis E
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal.
Condition: Hepatitis
Intervention: Biological: Hepatitis E vaccine, recombinant (Sar 56 kDa)
2 Completed Clinical Trial of Recombinant Hepatitis E Vaccine
Condition: Hepatitis E
Intervention: Biological: hepatitis E vaccine
3 Recruiting Role of Cytokines in Hepatitis E Virus Infection During Pregnancy
Conditions: Hepatitis;   Cytokines;   Pregnancy
Intervention:
4 Recruiting Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis
Conditions: Acute Hepatitis A;   Acute Hepatitis B;   Acute Hepatitis C;   Acute Hepatitis E;   Acute EBV Hepatitis;   Acute CMV Hepatitis
Interventions: Dietary Supplement: Silymarin;   Other: Lactose monohydrate
5 Completed Chiron Corp HCV E1/E2 Vaccine
Condition: Hepatitis C
Interventions: Biological: HCV E1E2/MF59;   Drug: Placebo
6 Completed Peg-Intron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (Study P04498)(COMPLETED)
Condition: Hepatitis B, Chronic
Interventions: Drug: Pegylated interferon alfa-2b;   Drug: Adefovir dipivoxil
7 Completed Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis
Condition: Pulmonary Tuberculosis
Intervention: Drug: ATT
8 Completed Study in Healthy Volunteers to Evaluate a Human Monoclonal Antibody Against Hepatitis C
Condition: Healthy
Intervention: Biological: MBL-HCV1
9 Completed A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection.
Condition: Hepatitis C, Chronic
Intervention: Drug: VCH-759 (BCH-27759)
10 Recruiting Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection Subjects
Condition: Chronic Hepatitis B
Interventions: Drug: albinterferon alfa-2b;   Drug: Pegasys®
11 Completed Blood Antioxidant Status in Chronic Hepatitis C Patients Before and After Antioxidant Supplementation: a Randomized Clinical Trial
Conditions: Hepatitis C;   Oxidative Stress
Intervention: Dietary Supplement: Antioxidant Supplementation
12 Recruiting Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention: Drug: Tenofovir/ & Emtricitabine
13 Completed A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen
Condition: Chronic Hepatitis B
Intervention: Drug: Entecavir
14 Completed A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen
Condition: Chronic Hepatitis B
Intervention: Drug: Entecavir
15 Completed PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (Study P05170)(COMPLETED)
Condition: Hepatitis B, Chronic
Intervention: Drug: pegylated interferon alpha-2b
16 Recruiting Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin
Condition: Chronic Hepatitis C
Intervention: Drug: Pegylated interferon alfa-2a and ribavirin
17 Completed Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: interferon alpha 2b plus ribavirin;   Drug: interferon alpha 2b plus placebo
18 Active, not recruiting 48 Weeks Combination Therapy for Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV) Infection
Condition: Hepatitis B
Interventions: Drug: Ribavirin;   Drug: Peginterferon alpha 2a
19 Completed Evaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study)
Conditions: Hepatitis C;   Thalassemia
Interventions: Drug: Peginterferon Alfa-2a and Ribavirin;   Drug: Ribavirin
20 Active, not recruiting Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease
Conditions: Thrombocytopenia;   Hepatitis C
Intervention: Drug: eltrombopag

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services